Literature DB >> 1906442

State of stupor from valproic acid during chronic treatment: case report.

S Gentile1, C Buffa, C Ravetti, I Sacerdote.   

Abstract

We describe the case of a 26 years old woman in chronic therapy with phenobarbital, carbamazepine, valproic acid (VPA) and clonazepam who showed a hyperammonemic encephalopathy after an increase in dosage of VPA. Similar cases have been reported, but with acute-subacute onset and no correlation with the plasma levels of VPA. Our case suggests the possibility that this toxic effect occurs during chronic treatment too, when the dosage of VPA is increased.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906442     DOI: 10.1007/bf02337037

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  24 in total

1.  Acute hepatic failure associated with the use of sodium valproate.

Authors:  F J Suchy; W F Balistreri; J J Buchino; J M Sondheimer; S R Bates; G L Kearns; J D Stull; K E Bove
Journal:  N Engl J Med       Date:  1979-04-26       Impact factor: 91.245

2.  Sodium valproate-induced hyperammonemia without clinical hepatic dysfunction.

Authors:  B S Zaret; R R Beckner; A M Marini; W Wagle; C Passarelli
Journal:  Neurology       Date:  1982-02       Impact factor: 9.910

3.  [Isolated hyperammonemia. A frequent consequence of treatment with sodium valproate].

Authors:  J M Warter; C Marescaux; L Rumbach; J Galmiche; G Micheletti; C Koehl; M Imler
Journal:  Nouv Presse Med       Date:  1981-11-14

4.  The renal origin of sodium valproate-induced hyperammonemia in fasting humans.

Authors:  J M Warter; C Brandt; C Marescaux; L Rumbach; G Micheletti; G Chabrier; J Krieger; M Imler
Journal:  Neurology       Date:  1983-09       Impact factor: 9.910

5.  Hypocarnitinemia in the handicapped individuals who receive a polypharmacy of antiepileptic drugs.

Authors:  J Morita; K Yuge; M Yoshino
Journal:  Neuropediatrics       Date:  1986-11       Impact factor: 1.947

6.  Valproate-induced hepatic injury: analyses of 23 fatal cases.

Authors:  H J Zimmerman; K G Ishak
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

7.  Asymptomatic hyperammonemia in patients receiving valproic acid.

Authors:  J V Murphy; K Marquardt
Journal:  Arch Neurol       Date:  1982-09

8.  Valproate-induced hyperammonaemia in two epileptic identical twins.

Authors:  R Campostrini; G Zaccara; L Rossi; M Paganini; A Dorigotti; R Zappoli
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

9.  Valproate-induced hyperammonemia.

Authors:  M L Batshaw; S W Brusilow
Journal:  Ann Neurol       Date:  1982-03       Impact factor: 10.422

10.  Stuporous episodes during treatment with sodium valproate: report of seven cases.

Authors:  C Marescaux; J M Warter; G Micheletti; L Rumbach; G Coquillat; D Kurtz
Journal:  Epilepsia       Date:  1982-06       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.